Name
Aktsiaselts Aconit
Registry code
10331560
VAT number
EE100623206
Type
AS - Joint Stock Company
Status
Registered
Foundation date
27.11.1997 (26)
Financial year
01.01-31.12
Capital
25 687.80 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Viktor Gofaizen 29.07.1960 (64) | 22% - 5 559.30 EUR | - | - | Board memberShareholder |
| Diana Sinisalu 10.07.1975 (49) | 13% - 3 450.60 EUR | Board member | Direct ownership | Shareholder |
| Mihhail Gofaizen 24.10.1954 (70) | 65% - 16 677.90 EUR | - | Direct ownership | Shareholder |
| Olga Kaminskaja 12.09.1972 (52) | - | - | - | Board member |
| Olga Tolmatšova 12.02.1957 (67) | - | - | - | Board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Aconit Dental OÜ 12445776 | 70% - 1 750.00 EUR | - | - | Founder |
| 2019 13.09.2020 | 2020 28.07.2021 | 2021 04.07.2022 | 2022 14.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 292 821 € | 300 853 € | 310 315 € | 346 601 € |
| Net profit (loss) for the period | 40 € | 4 603 € | 1 721 € | 2 366 € |
| Profit Margin | 0% | 2% | 1% | 1% |
| Current Assets | 148 865 € | 164 201 € | 129 994 € | 96 927 € |
| Fixed Assets | 5 205 € | 3 709 € | 13 233 € | 115 238 € |
| Total Assets | 154 070 € | 167 910 € | 143 227 € | 212 165 € |
| Current Liabilities | 103 777 € | 118 774 € | 97 650 € | 68 322 € |
| Non Current Liabilities | - | - | - | 99 100 € |
| Total Liabilities | - | - | - | 167 422 € |
| Share Capital | 25 688 € | 25 688 € | 25 688 € | 25 688 € |
| Equity | 50 293 € | 49 136 € | 45 577 € | 44 743 € |
| Employees | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 153 018.31 € | 10 239.93 € | 2 478.87 € | 3 |
| 2023 Q4 | 126 695.33 € | 10 710.5 € | 2 448.78 € | 3 |
| 2023 Q3 | 189 504.14 € | 10 004.1 € | 2 448.78 € | 3 |
| 2023 Q2 | 158 671.06 € | 10 744.44 € | 2 388.22 € | 3 |
| 2023 Q1 | 159 500.94 € | 11 389.38 € | 3 680 € | 3 |
| 2022 Q4 | 311 857.91 € | 13 287.62 € | 3 646.95 € | 4 |
| 2022 Q3 | 153 340.28 € | 10 667.72 € | 2 547.88 € | 4 |
| 2022 Q2 | 185 388.56 € | 14 694.17 € | 2 352.67 € | 3 |
| 2022 Q1 | 96 008.57 € | 8 491.09 € | 2 124.99 € | 3 |
| 2021 Q4 | 154 833.52 € | 12 232.65 € | 2 252.22 € | 3 |
| 2021 Q3 | 153 455.67 € | 9 203.61 € | 2 328.52 € | 3 |
| 2021 Q2 | 191 079.72 € | 10 149.44 € | 2 353.02 € | 3 |
| 2021 Q1 | 127 079.95 € | 9 963.66 € | 2 319.42 € | 3 |
| 2020 Q4 | 154 639.61 € | 10 646.11 € | 2 124.76 € | 3 |
| 2020 Q3 | 119 013.02 € | 11 475.79 € | 2 252.22 € | 3 |
| 2020 Q2 | 136 562.27 € | 11 121.29 € | 2 294.92 € | 3 |
| 2020 Q1 | 128 266.07 € | 8 599.23 € | 2 143.7 € | 3 |
